We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.88T
1-Year Est. Return 44.46%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+0.67%
1 Year Est. Return
+44.46%
3 Year Est. Return
+136.69%
5 Year Est. Return
+180.19%
10 Year Est. Return
+697.06%
AUM
$743B
AUM Growth
+$17B
Cap. Flow
+$20.9B
Cap. Flow %
2.82%
Top 10 Hldgs %
22.73%
Holding
4,944
New
223
Increased
2,961
Reduced
1,210
Closed
86

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$887M
2
AMZN icon
Amazon
AMZN
+$857M
3
AAPL icon
Apple
AAPL
+$844M
4
MSFT icon
Microsoft
MSFT
+$802M
5
TSLA icon
Tesla
TSLA
+$606M

Sector Composition

Rank Sector Weight
1 Technology 24.53%
2 Financials 13.97%
3 Healthcare 13.42%
4 Consumer Discretionary 11.85%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABCM
4401
DELISTED
Abcam PLC
ABCM
$224K ﹤0.01%
11,087
CREX icon
4402
Creative Realities
CREX
$39.3M
$223K ﹤0.01%
55,144
+3,335
+6% +$16K
ELVN icon
4403
Enliven Therapeutics
ELVN
$4.24B
$223K ﹤0.01%
13,694
+826
+6% +$17.2K
HEXO
4404
DELISTED
HEXO Corp. Common Shares
HEXO
$223K ﹤0.01%
8,717
+5,766
+195% +$267K
BLCM
4405
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$223K ﹤0.01%
76,533
+17,874
+30% +$54.5K
QTEK
4406
DELISTED
QualTek Services Inc. Class A Common Stock
QTEK
$223K ﹤0.01%
22,514
BKTI icon
4407
BK Technologies
BKTI
$292M
$222K ﹤0.01%
15,766
IMCR icon
4408
Immunocore
IMCR
$1.77B
$222K ﹤0.01%
5,997
FSRD
4409
DELISTED
Fast Radius, Inc. Class A Common Stock
FSRD
$222K ﹤0.01%
22,493
CADL icon
4410
Candel Therapeutics
CADL
$783M
$221K ﹤0.01%
+20,395
New +$169K
NINE
4411
DELISTED
Nine Energy Service
NINE
$221K ﹤0.01%
120,782
+4,557
+4% +$10.2K
SRRA
4412
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$220K ﹤0.01%
+10,075
New +$202K
KOR
4413
DELISTED
Corvus Gold Inc. Common Shares
KOR
$219K ﹤0.01%
68,732
+3,873
+6% +$12K
GMBT
4414
DELISTED
Pivotal Holdings Corp Class A Ordinary Share
GMBT
$218K ﹤0.01%
22,172
CRDL
4415
Cardiol Therapeutics
CRDL
$175M
$217K ﹤0.01%
+52,435
New +$190K
PSHG icon
4416
Performance Shipping
PSHG
$21.8M
$217K ﹤0.01%
2,684
PHIO icon
4417
Phio Pharmaceuticals
PHIO
$12.5M
$216K ﹤0.01%
993
+183
+23% +$38.2K
GHSI
4418
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$215K ﹤0.01%
3,397
SOLO
4419
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
$215K ﹤0.01%
60,611
INDP icon
4420
Indaptus Therapeutics
INDP
$136M
$214K ﹤0.01%
+980
New +$283K
ACOR
4421
DELISTED
Acorda Therapeutics
ACOR
$214K ﹤0.01%
2,336
-1,342
-36% -$111K
XBIO icon
4422
Xenetic Biosciences
XBIO
$7.56M
$213K ﹤0.01%
10,415
+5,364
+106% +$146K
PIXY
4423
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
$212K ﹤0.01%
5
+3
+150% +$173K
DALN
4424
DELISTED
DallasNews
DALN
$211K ﹤0.01%
30,474
LKFT
4425
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
$211K ﹤0.01%
4,027
+132
+3% +$7.84K

Similar funds

Geode Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
  • Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
  • Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
  • Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
  • Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
  • Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
  • Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.

Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.